These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation. Voigt N, Rozmaritsa N, Trausch A, Zimniak T, Christ T, Wettwer E, Matschke K, Dobrev D, Ravens U. Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):251-9. PubMed ID: 19760273 [Abstract] [Full Text] [Related]
6. The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation. Wettwer E, Christ T, Endig S, Rozmaritsa N, Matschke K, Lynch JJ, Pourrier M, Gibson JK, Fedida D, Knaut M, Ravens U. Cardiovasc Res; 2013 Apr 01; 98(1):145-54. PubMed ID: 23341576 [Abstract] [Full Text] [Related]
10. Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation. Workman AJ, Kane KA, Rankin AC. Cardiovasc Res; 2003 Sep 01; 59(3):593-602. PubMed ID: 14499860 [Abstract] [Full Text] [Related]
12. [Increased small conductance calcium-activated potassium channel (SK2 channel) current in atrial myocytes of patients with persistent atrial fibrillation]. Li ML, Li T, Lei M, Tan XQ, Yang Y, Liu TP, Pei J, Zeng XR. Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb 01; 39(2):147-51. PubMed ID: 21426750 [Abstract] [Full Text] [Related]
14. The ultrarapid and the transient outward K(+) current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation. Brandt MC, Priebe L, Böhle T, Südkamp M, Beuckelmann DJ. J Mol Cell Cardiol; 2000 Oct 01; 32(10):1885-96. PubMed ID: 11013132 [Abstract] [Full Text] [Related]
15. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS, Nerbonne JM. Circ Res; 1997 Jun 01; 80(6):772-81. PubMed ID: 9168779 [Abstract] [Full Text] [Related]
18. Selective block of sarcolemmal IKATP in human cardiomyocytes using HMR 1098. Kääb S, Zwermann L, Barth A, Hinterseer M, Englert HC, Gögelein H, Näbauer M. Cardiovasc Drugs Ther; 2003 Jun 01; 17(5-6):435-41. PubMed ID: 15107598 [Abstract] [Full Text] [Related]